AIMC Topic: Antifibrotic Agents

Clear Filters Showing 1 to 4 of 4 articles

Initiation of antifibrotic treatment in fibrosing interstitial lung disease: is the clock ticking till proven progression?

European respiratory review : an official journal of the European Respiratory Society
Several interstitial lung diseases (ILDs) with different aetiologies and pathogenic mechanisms may exhibit a progressive behaviour, similar to idiopathic pulmonary fibrosis, with comparable functional decline and early mortality. Progressive pulmonar...

A high-throughput analysis of novel anti-fibrotics in human adult cardiac fibroblasts.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Myocardial fibrosis, a hallmark of heart failure (HF), contributes to disease progression and mortality by impairing cardiac function. Despite the identification of potential anti-fibrotic molecules, there is a lack of effective pharmacological inter...

Deep-DPC: Deep learning-assisted label-free temporal imaging discovery of anti-fibrotic compounds by controlling cell morphology.

Journal of advanced research
INTRODUCTION: Fibrosis can damage the normal function of many organs, such as cardiac function, for which no effective clinical therapies exist. However, traditional approaches to anti-fibrosis drug discovery have primarily focused on the final biolo...

[Evaluation of the efficacy of antifibrotic drugs on cell cultures in Salzmann's nodular degeneration].

Vestnik oftalmologii
UNLABELLED: Excessive production of extracellular matrix is a key component in the pathogenesis of Salzmann's nodular degeneration (SND). studies of drugs that suppress excessive fibroblast activity may become crucial in developing pathogenetically ...